Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Treatment for Obstetric Fistula Found Effective

By HospiMedica International staff writers
Posted on 31 Dec 2008
Surgical repair provides good long-term outcomes in women suffering from an obstetric fistula, according to a new study.

Researchers from the Hamlin Fistula Center (Bahir Dar, Ethiopia), a dedicated unit for treating women with obstetric fistula in northern Ethiopia, conducted a prospective study of all women admitted to the center suffering from vesicovaginal (VF) and rectovaginal fistulae (RVF). More...
A total of 390 women were asked to return for a follow-up appointment six months after surgical treatment. The women were questioned at discharge and at follow-up appointment, using a standardized questionnaire, and an examination was performed. The information was then entered into a database.

The researchers found that only eight women (2.1%) had a failed VF repair, but 95 women (24.3%) in whom the fistula appeared to be closed still had urethral incontinence. Twenty-two of the 141 women who were cured at discharge and returned for follow-up came back leaking with an incontinence grade of 2-4. Just over half (53%) of 92 women who were discharged with urethral incontinence returned with the same incontinence grade and 44% returned with their incontinence score improved or with their fistula now healed or retention resolved. However, 15% of the women cured at discharge returned with their incontinence grade worse or with urinary retention or fistula recurrence. By six months after repair, one-third of women had resumed sexual activity (without pain in 90%) and 83% reported that the operation had at least moderately improved their quality of life. The study was published in the November 2008 issue of BJOG: An International Journal of Obstetrics and Gynaecology.

"Continence gains immediately after the operation are largely maintained at six months. There is one notable finding that some women have a recurrence of their fistula after being discharged cured, and this certainly needs to be looked at with the view to improving this outcome,” said lead author Andrew Browning, M.D. "We have made steps to decrease the incontinence rates with the adoption of some new surgical techniques. This has resulted in a drop from 33-55% to 23% in short-term incontinence rates. Further research needs to be done to decrease this rate even further, but any developments need to be simple and cheap for the developing world setting.”

Obstetric fistula is a severe medical condition in which a fistula develops between the rectum and vagina (rectovaginal fistula) or between the bladder and vagina (vesicovaginal fistula) after severe or failed childbirth, when adequate medical care is not available. The fistula usually develops when a prolonged labor presses the unborn child so tightly in the birth canal that blood flow is cut off to the surrounding tissues, which necrotize and eventually rot away. More rarely, the injury can be caused by female genital cutting, poorly performed abortions, pelvic fractures, or rape.

Related LInks:
Hamlin Fistula Center


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.